Entry Point Capital, LLC Quanterix Corp Transaction History

Entry Point Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$6.51 - $12.08 $29,054 - $53,913	-4,463 Reduced 12.57%	31,041 $202,000
Q4 2024 Feb 11, 2025	BUY	$9.99 - $15.39 $191,837 - $295,534	19,203 Added 117.8%	35,504 $377,000
Q3 2024 Nov 13, 2024	BUY	$10.92 - $16.36 $170,144 - $254,905	15,581 Added 2164.03%	16,301 $211,000
Q2 2024 Aug 13, 2024	BUY	$12.26 - $23.78 $8,827 - $17,121	720 New	720 $9.51 Million

140

36.1M

10.6K

13.8K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $212M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Entry Point Capital, LLC with notifications on news.